Results 41 to 50 of about 3,456,371 (289)

Analysis of risk factors associated with cerebral angiography headache

open access: yesArquivos de Neuro-Psiquiatria, 2023
Background Despite previous studies indicating a moderate/high incidence of angiography headache (AH), there is still limited data about the risk factors associated with its occurrence.
Tiago Madeira   +3 more
doaj   +1 more source

Epicranial headaches part 2: Nummular headache and epicrania fugax

open access: yesCephalalgia, 2023
Background Nummular headache and epicrania fugax are two primary headaches that fall under the heading of epicranial headaches. Methods This article reviews the epidemiological and clinical features of nummular headache and epicrania fugax, proposed ...
M. Cuadrado
semanticscholar   +1 more source

Cognitive Status in People With Epilepsy in the Republic of Guinea: A Prospective, Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick   +14 more
wiley   +1 more source

Migraine and other headaches in transient ischemic attacks

open access: yesНеврология, нейропсихиатрия, психосоматика, 2019
Headache is a common symptom in acute cerebrovascular diseases; however, no studies have evaluated the prevalence of specific headache types in patients with transient ischemic attacks (ТIАs).Objective: to analyze all headaches within the last year and ...
E. R. Lebedeva, N. M. Gurary, J. Olesen
doaj   +1 more source

Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones   +3 more
wiley   +1 more source

Approach to Headache in Patients with COVID-19

open access: yesActa Médica Portuguesa, 2021
N/a.
Andreia Costa   +2 more
doaj   +1 more source

The Secondary Headaches [PDF]

open access: yesCephalalgia, 2021
Anish Bahra, Randolph W Evans
openaire   +2 more sources

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Clinical Effectiveness of Primary and Secondary Headache Treatment by Transcranial Direct Current Stimulation

open access: yesFrontiers in Neurology, 2013
The clinical effectiveness of primary and secondary headache treatment by transcranial direct current stimulation (tDCS) with various locations of stimulating electrodes on the scalp was analyzed retrospectively.
D. Pinchuk   +3 more
semanticscholar   +1 more source

Information theory and headache triggers

open access: yesHeadache, 2023
This secondary analysis evaluated the information content exhibited by various measurement strategies of commonly perceived causes, or “triggers,” of headache attacks.
D. P. Turner   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy